- Home
- TWST vs MLTX Comparison
TWST vs MLTX Comparison
Compare TWST & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWST
- MLTX
- Stock Information
- Founded
- TWST 2013
- MLTX 2021
- Country
- TWST United States
- MLTX Switzerland
- Employees
- TWST N/A
- MLTX N/A
- Industry
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- TWST Health Care
- MLTX Health Care
- Exchange
- TWST Nasdaq
- MLTX Nasdaq
- Market Cap
- TWST 2.7B
- MLTX 3.4B
- IPO Year
- TWST 2018
- MLTX N/A
- Fundamental
- Price
- TWST $42.75
- MLTX $46.50
- Analyst Decision
- TWST Buy
- MLTX Buy
- Analyst Count
- TWST 9
- MLTX 7
- Target Price
- TWST $52.33
- MLTX $80.20
- AVG Volume (30 Days)
- TWST 732.2K
- MLTX 296.9K
- Earning Date
- TWST 01-31-2025
- MLTX 02-27-2025
- Dividend Yield
- TWST N/A
- MLTX N/A
- EPS Growth
- TWST N/A
- MLTX N/A
- EPS
- TWST N/A
- MLTX N/A
- Revenue
- TWST $312,974,000.00
- MLTX N/A
- Revenue This Year
- TWST $21.67
- MLTX N/A
- Revenue Next Year
- TWST $17.52
- MLTX N/A
- P/E Ratio
- TWST N/A
- MLTX N/A
- Revenue Growth
- TWST 27.69
- MLTX N/A
- 52 Week Low
- TWST $27.41
- MLTX $37.55
- 52 Week High
- TWST $60.90
- MLTX $64.98
- Technical
- Relative Strength Index (RSI)
- TWST 39.06
- MLTX 36.71
- Support Level
- TWST $41.06
- MLTX $43.64
- Resistance Level
- TWST $51.31
- MLTX $56.00
- Average True Range (ATR)
- TWST 2.54
- MLTX 2.49
- MACD
- TWST -0.61
- MLTX -0.95
- Stochastic Oscillator
- TWST 16.49
- MLTX 23.14
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.